BioSpace News Archive

ETX2514SUL was generally well tolerated

PaceMate™ is pleased to announce that as of August 15, 2018, the Arizona Heart Rhythm Center will be the first organization in the state of Arizona to offer automated remote monitoring of cardiac implantable electronic devices.

inVibe Labs has just expanded its Philadelphia-based team with the hiring of two healthcare industry veterans, Beth Baldys and Donna Wray.

Elligo Health Research announces its partnership with Women’s Health USA.

Onspira Therapeutics, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to its investigational product, OSP-101

ND acceptance triggers $2M milestone payment from CANbridge to AVEO.

Aradigm Corporation announced financial results for the second quarter and six months ended June 30, 2018.

Allogene Therapeutics, Inc. announced the appointment of Susie Jun, M.D., Ph.D., as Chief Development Officer.

CANbridge Life Sciences, a biopharmaceutical company developing Western drug candidates in China and North Asia, announced that the China National Drug Administration (CNDA) has approved the Investigational New Drug (IND) application for a Phase Ib/III clinical study of CAN017 in esophageal squamous cell cancer (ESCC).

Ironshore Pharmaceuticals & Development, Inc. announced that it has entered into agreements with purchasers to raise approximately US$143 million at a purchase price of 98% by way of a private placement of Senior Secured Notes.